chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: F
Vaccine: JEV
Symptoms: Chills, Headache, Injection site rash, Myalgia, Nausea
Clinical narrative: Given Japanese encephalitis vaccine #1 in clinic on 2-21-08 at 2:55 pm. Developed low-grade fever, chills, myalgias, nausea, and headache afterwards but no rash or hives.  Self-limited; lasted 1-2 days.  Given Japanese encephalitis vaccine #2 in clinic on 2-28-08 at 12:45 pm.  The next day she developed fever, chills, and rash at the injection site, which spread to her arms, legs, and trunk, but not palms or soles.  No oral lesions, swelling, hives, or shortness of breath.  This lasted 3-4 days with gradual improvement.  Rash is starting to fade, and fever has come down; however, low grade fever persists as of 3-3-08.  Should be noted that she started Bactrim DS 2 tabs bid for abdominal MRSA on 2-28-08.  However, she is still taking the drug, and the rash is starting to fade.
Age: 27.0
Sex: F
Vaccine: JEV
Symptoms: Pyrexia, Rash, Vaccine positive rechallenge
Clinical narrative: Given Japanese encephalitis vaccine #1 in clinic on 2-21-08 at 2:55 pm. Developed low-grade fever, chills, myalgias, nausea, and headache afterwards but no rash or hives.  Self-limited; lasted 1-2 days.  Given Japanese encephalitis vaccine #2 in clinic on 2-28-08 at 12:45 pm.  The next day she developed fever, chills, and rash at the injection site, which spread to her arms, legs, and trunk, but not palms or soles.  No oral lesions, swelling, hives, or shortness of breath.  This lasted 3-4 days with gradual improvement.  Rash is starting to fade, and fever has come down; however, low grade fever persists as of 3-3-08.  Should be noted that she started Bactrim DS 2 tabs bid for abdominal MRSA on 2-28-08.  However, she is still taking the drug, and the rash is starting to fade.
Age: 0.36
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5
Symptoms: Barium enema, Barium enema abnormal, Diarrhoea, Intussusception, Laparoscopy
Clinical narrative: Patient received immunization 2/22/08.  On 3/3/88 patient developed vomiting and diarrhea.  Admitted to the hospital 3/5/08.  Barium enema revealed intussusception.  Unable to reduce in radiology, taken to the operating room for surgical laparoscopic reduction.  04/07/2008 MR received for DOS 3/5-7/2008 with D/C DX: Intussusception.  Laparoscopic reduction of Intussusception.   Infant presented to hospital with bilious vomiting and one bout of hematochezia, decreased activity and very sleepy. Pt was recovering from a recent respiratory infection which was improving on abx.  PE(+) for palpable bowel loop in RLQ, (+) abd tenderness, mild to moderately dehydrated and fussy. Intussusception seen on Barium Enema but unable to reduce.  Taken to OR for a Laparoscopic reduction of IS. A small serosal tear was identified on the terminal ileum.  Tolerated surgery well and d/c on  POD #2.
Age: 0.36
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5
Symptoms: Vomiting
Clinical narrative: Patient received immunization 2/22/08.  On 3/3/88 patient developed vomiting and diarrhea.  Admitted to the hospital 3/5/08.  Barium enema revealed intussusception.  Unable to reduce in radiology, taken to the operating room for surgical laparoscopic reduction.  04/07/2008 MR received for DOS 3/5-7/2008 with D/C DX: Intussusception.  Laparoscopic reduction of Intussusception.   Infant presented to hospital with bilious vomiting and one bout of hematochezia, decreased activity and very sleepy. Pt was recovering from a recent respiratory infection which was improving on abx.  PE(+) for palpable bowel loop in RLQ, (+) abd tenderness, mild to moderately dehydrated and fussy. Intussusception seen on Barium Enema but unable to reduce.  Taken to OR for a Laparoscopic reduction of IS. A small serosal tear was identified on the terminal ileum.  Tolerated surgery well and d/c on  POD #2.
Age: 0.36
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5
Symptoms: Abdominal mass, Abdominal tenderness, Barium enema abnormal, Decreased activity, Dehydration
Clinical narrative: Patient received immunization 2/22/08.  On 3/3/88 patient developed vomiting and diarrhea.  Admitted to the hospital 3/5/08.  Barium enema revealed intussusception.  Unable to reduce in radiology, taken to the operating room for surgical laparoscopic reduction.  04/07/2008 MR received for DOS 3/5-7/2008 with D/C DX: Intussusception.  Laparoscopic reduction of Intussusception.   Infant presented to hospital with bilious vomiting and one bout of hematochezia, decreased activity and very sleepy. Pt was recovering from a recent respiratory infection which was improving on abx.  PE(+) for palpable bowel loop in RLQ, (+) abd tenderness, mild to moderately dehydrated and fussy. Intussusception seen on Barium Enema but unable to reduce.  Taken to OR for a Laparoscopic reduction of IS. A small serosal tear was identified on the terminal ileum.  Tolerated surgery well and d/c on  POD #2.
Age: 0.36
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5
Symptoms: Diarrhoea, Enema administration, Full blood count abnormal, Haematochezia, Haematocrit normal
Clinical narrative: Patient received immunization 2/22/08.  On 3/3/88 patient developed vomiting and diarrhea.  Admitted to the hospital 3/5/08.  Barium enema revealed intussusception.  Unable to reduce in radiology, taken to the operating room for surgical laparoscopic reduction.  04/07/2008 MR received for DOS 3/5-7/2008 with D/C DX: Intussusception.  Laparoscopic reduction of Intussusception.   Infant presented to hospital with bilious vomiting and one bout of hematochezia, decreased activity and very sleepy. Pt was recovering from a recent respiratory infection which was improving on abx.  PE(+) for palpable bowel loop in RLQ, (+) abd tenderness, mild to moderately dehydrated and fussy. Intussusception seen on Barium Enema but unable to reduce.  Taken to OR for a Laparoscopic reduction of IS. A small serosal tear was identified on the terminal ileum.  Tolerated surgery well and d/c on  POD #2.
Age: 0.36
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5
Symptoms: Intussusception, Irritability, Laparoscopy, Red blood cell count normal, Small intestinal intussusception reduction
Clinical narrative: Patient received immunization 2/22/08.  On 3/3/88 patient developed vomiting and diarrhea.  Admitted to the hospital 3/5/08.  Barium enema revealed intussusception.  Unable to reduce in radiology, taken to the operating room for surgical laparoscopic reduction.  04/07/2008 MR received for DOS 3/5-7/2008 with D/C DX: Intussusception.  Laparoscopic reduction of Intussusception.   Infant presented to hospital with bilious vomiting and one bout of hematochezia, decreased activity and very sleepy. Pt was recovering from a recent respiratory infection which was improving on abx.  PE(+) for palpable bowel loop in RLQ, (+) abd tenderness, mild to moderately dehydrated and fussy. Intussusception seen on Barium Enema but unable to reduce.  Taken to OR for a Laparoscopic reduction of IS. A small serosal tear was identified on the terminal ileum.  Tolerated surgery well and d/c on  POD #2.
Age: 0.36
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5
Symptoms: Somnolence, Urinary system X-ray, Vomiting, White blood cell count increased, X-ray gastrointestinal tract normal
Clinical narrative: Patient received immunization 2/22/08.  On 3/3/88 patient developed vomiting and diarrhea.  Admitted to the hospital 3/5/08.  Barium enema revealed intussusception.  Unable to reduce in radiology, taken to the operating room for surgical laparoscopic reduction.  04/07/2008 MR received for DOS 3/5-7/2008 with D/C DX: Intussusception.  Laparoscopic reduction of Intussusception.   Infant presented to hospital with bilious vomiting and one bout of hematochezia, decreased activity and very sleepy. Pt was recovering from a recent respiratory infection which was improving on abx.  PE(+) for palpable bowel loop in RLQ, (+) abd tenderness, mild to moderately dehydrated and fussy. Intussusception seen on Barium Enema but unable to reduce.  Taken to OR for a Laparoscopic reduction of IS. A small serosal tear was identified on the terminal ileum.  Tolerated surgery well and d/c on  POD #2.
Age: 0.36
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5
Symptoms: Intussusception, Surgery
Clinical narrative: Patient received immunization 2/22/08.  On 3/3/88 patient developed vomiting and diarrhea.  Admitted to the hospital 3/5/08.  Barium enema revealed intussusception.  Unable to reduce in radiology, taken to the operating room for surgical laparoscopic reduction.  04/07/2008 MR received for DOS 3/5-7/2008 with D/C DX: Intussusception.  Laparoscopic reduction of Intussusception.   Infant presented to hospital with bilious vomiting and one bout of hematochezia, decreased activity and very sleepy. Pt was recovering from a recent respiratory infection which was improving on abx.  PE(+) for palpable bowel loop in RLQ, (+) abd tenderness, mild to moderately dehydrated and fussy. Intussusception seen on Barium Enema but unable to reduce.  Taken to OR for a Laparoscopic reduction of IS. A small serosal tear was identified on the terminal ileum.  Tolerated surgery well and d/c on  POD #2.
Age: 4.0
Sex: F
Vaccine: DTAP, HEPA, IPV, MMR, VARCEL
Symptoms: Cellulitis, Erythema
Clinical narrative: Pt had redness on 3/6/7 on upper L arm that appears to be cellulitis. DTaP and IPV were Aventis.  Pt also had PPD placed on Left forearm.
Age: 0.33
Sex: M
Vaccine: DTAP, HIBV, PNC, RV5, DTAP, HIBV, PNC, RV5
Symptoms: Intussusception, Surgery
Clinical narrative: Intussusception requiring surgical reduction occurred 3/1/08. 03/14/2008 MR received for DOS 3/01-04/2008 with D/C DX:  S/P Exploratory Laparotomy.  Reduction of Intussusception.  Appendectomy.  Infant presented to local hospital with abdominal pain, vomiting and bloody stools. Recent URI. Intussusception noted on abdominal CT and pt transfered to current facility for tx. Air enema unsuccessful at reduction and pt to OR for Ex Lap and reduction of IS.  pt experience post-op fevers.  Taking po on POD#2 and D/C home on POD#3. Seen again in ER 3/5/08 after no BM and fussiness.  Glycerine supp given for constipation.
Age: 0.33
Sex: M
Vaccine: DTAP, HIBV, PNC, RV5, DTAP, HIBV, PNC, RV5
Symptoms: Abdominal pain, Appendicectomy, Barium double contrast, Computerised tomogram abnormal, Constipation
Clinical narrative: Intussusception requiring surgical reduction occurred 3/1/08. 03/14/2008 MR received for DOS 3/01-04/2008 with D/C DX:  S/P Exploratory Laparotomy.  Reduction of Intussusception.  Appendectomy.  Infant presented to local hospital with abdominal pain, vomiting and bloody stools. Recent URI. Intussusception noted on abdominal CT and pt transfered to current facility for tx. Air enema unsuccessful at reduction and pt to OR for Ex Lap and reduction of IS.  pt experience post-op fevers.  Taking po on POD#2 and D/C home on POD#3. Seen again in ER 3/5/08 after no BM and fussiness.  Glycerine supp given for constipation.
Age: 0.33
Sex: M
Vaccine: DTAP, HIBV, PNC, RV5, DTAP, HIBV, PNC, RV5
Symptoms: Enema administration, Explorative laparotomy, Haematochezia, Intussusception, Irritability
Clinical narrative: Intussusception requiring surgical reduction occurred 3/1/08. 03/14/2008 MR received for DOS 3/01-04/2008 with D/C DX:  S/P Exploratory Laparotomy.  Reduction of Intussusception.  Appendectomy.  Infant presented to local hospital with abdominal pain, vomiting and bloody stools. Recent URI. Intussusception noted on abdominal CT and pt transfered to current facility for tx. Air enema unsuccessful at reduction and pt to OR for Ex Lap and reduction of IS.  pt experience post-op fevers.  Taking po on POD#2 and D/C home on POD#3. Seen again in ER 3/5/08 after no BM and fussiness.  Glycerine supp given for constipation.
Age: 0.33
Sex: M
Vaccine: DTAP, HIBV, PNC, RV5, DTAP, HIBV, PNC, RV5
Symptoms: Large intestinal obstruction reduction, Pyrexia, Surgery, Vomiting
Clinical narrative: Intussusception requiring surgical reduction occurred 3/1/08. 03/14/2008 MR received for DOS 3/01-04/2008 with D/C DX:  S/P Exploratory Laparotomy.  Reduction of Intussusception.  Appendectomy.  Infant presented to local hospital with abdominal pain, vomiting and bloody stools. Recent URI. Intussusception noted on abdominal CT and pt transfered to current facility for tx. Air enema unsuccessful at reduction and pt to OR for Ex Lap and reduction of IS.  pt experience post-op fevers.  Taking po on POD#2 and D/C home on POD#3. Seen again in ER 3/5/08 after no BM and fussiness.  Glycerine supp given for constipation.
Age: 46.0
Sex: F
Vaccine: HEPAB
Symptoms: Abdominal pain upper, Diarrhoea, Erythema, Eyelid oedema, Nausea
Clinical narrative: 3-4-08 rec'd Twinrix.  3-5-08 client states had diarrhea, stomach cramps & nausea. 3-6-08 client noticed neck was reddened, saw private doctor that day for scheduled appt. Doctor told client to take Benadryl.  Client took Claritin, but later that day developed rash with swollen eyelids.  Client called health dept, who advised her to call her physician for re-evaluation.  Client denied any wheezing or difficulty breathing, and agreed to seek emergency care if that developed.  3-7-08 Client reports did not call doctor again, and that rash is improved, and does not now have swelling.  Client states will contact doctor if condition worsens.
Age: 46.0
Sex: F
Vaccine: HEPAB
Symptoms: Rash
Clinical narrative: 3-4-08 rec'd Twinrix.  3-5-08 client states had diarrhea, stomach cramps & nausea. 3-6-08 client noticed neck was reddened, saw private doctor that day for scheduled appt. Doctor told client to take Benadryl.  Client took Claritin, but later that day developed rash with swollen eyelids.  Client called health dept, who advised her to call her physician for re-evaluation.  Client denied any wheezing or difficulty breathing, and agreed to seek emergency care if that developed.  3-7-08 Client reports did not call doctor again, and that rash is improved, and does not now have swelling.  Client states will contact doctor if condition worsens.
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMR
Symptoms: Cellulitis, Erythema, Oedema peripheral
Clinical narrative: Pt rec'd DTaP vaccine on 3/3/08 and after that, right thigh became red and swollen.  Family was using Ibuprofen, Benadryl and ice.  On 3/6/08, family returned to office and was started on cephalexin for cellulitis and told to continue Motrin and change to heat therapy.
Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash, Rash pruritic, Tenderness
Clinical narrative: Client called today and stated she had pink, rough rash over and into L eyebrow which is pruritic and tender.  No drainage, no vision problems.  Rash as been present since early February, she does not know the date when she was first aware of rash, and rash is now resolving.
Age: 50.0
Sex: F
Vaccine: HEP
Symptoms: Dizziness, Muscular weakness
Clinical narrative: Weakness of muscles and dizziness.
Age: 58.0
Sex: U
Vaccine: PPV
Symptoms: Chronic obstructive pulmonary disease
Clinical narrative: Subject in pneumococcal vaccine trial, with severe COPD, was hospitalized with a COPD exacerbation.  Vaccination took place on 9/19/07 and hospital admission was on 11/06/07. According to physician, relationship to treatment is 'None'.  We would be happy to forward the Study's SAE Report Form upon request.
Age: 7.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Blood product transfusion, Hemiparesis, Myelitis transverse, Nuclear magnetic resonance imaging abnormal
Clinical narrative: Transverse myelitis with hemiparesis truncal weakness, MRI changes in spinal cord from C4 to T 11   Onset of transverse myelitis 2/20/2008 Vaccine given 11/19/2007  IVIG, Steroids given for transverse myelitis given during hospitalization at Hospital.  Patient now in Rehab hospital.  3/11/08 Reviewed D/C summary from hospital for 2/23-3/07/2008 admission. FINAL DX: Transverse myelitis. Patient experienced progressive ascending paralysis x 2 days, back pain, balance difficulty w/falls & fever.  On admission, was unable to walk, had to crawl.  Patient transferred from outlying ER to PICU. Neuro consult done.  Tx w/IVIG x 4, IV steroids & pain meds.  Transferred to ped floor, improved  to be able to walk w/walker & d/c to inpatient rehab on tapering steroids.   3/11/08 Received additional hospital  med records which reveal patient also experienced right foot pain & weakness which quickly progressed to paraplegia w/urinary incontinence, areflexia & absence of pain sensation.  Optho exam WNL.
Age: 0.47
Sex: F
Vaccine: MNQ
Symptoms: Aphasia, Autism, Childhood disintegrative disorder, Cognitive disorder, Ear infection
Clinical narrative: My daughter was developmentally on target at time of vaccination.  After she Accidently got the Wrong Vaccine (Menigiccoconal instead of Prevnar) at 6mo old, she started falling behind.  7 mos old- Cognitive stopped, her speach (sounds) stopped completley, she stopped responding to her name, and other misc symptoms. Repeated Ear ache/infections.  She's 27 mos now, and still won't speak.  We thought she was deaf! Until after a year of specialists and missed work for evaluations and tests told me she was AUTISTIC!  3/21/08 Reviewed pcp medical records. FINAL DX: PDD, mixed receptive-expressive language disorder; global developmental delay; low tone. Records reveal patient experienced good health on day of vax.  Received vax in error.  Noted to have irritability & abscess on left buttock on 5/28/06 which was aspirated & tx w/antibiotics.  Worsened & advised to go to ER.  Next office vs on 8/17/06 when parent described behavior problems & screaming.  Referred to SLP, mental health counselor, audiology, developmental pediatrician, PT/OT, Autism Clinic, Psychologist
Age: 0.47
Sex: F
Vaccine: MNQ
Symptoms: Ear pain, Speech disorder developmental, Wrong drug administered
Clinical narrative: My daughter was developmentally on target at time of vaccination.  After she Accidently got the Wrong Vaccine (Menigiccoconal instead of Prevnar) at 6mo old, she started falling behind.  7 mos old- Cognitive stopped, her speach (sounds) stopped completley, she stopped responding to her name, and other misc symptoms. Repeated Ear ache/infections.  She's 27 mos now, and still won't speak.  We thought she was deaf! Until after a year of specialists and missed work for evaluations and tests told me she was AUTISTIC!  3/21/08 Reviewed pcp medical records. FINAL DX: PDD, mixed receptive-expressive language disorder; global developmental delay; low tone. Records reveal patient experienced good health on day of vax.  Received vax in error.  Noted to have irritability & abscess on left buttock on 5/28/06 which was aspirated & tx w/antibiotics.  Worsened & advised to go to ER.  Next office vs on 8/17/06 when parent described behavior problems & screaming.  Referred to SLP, mental health counselor, audiology, developmental pediatrician, PT/OT, Autism Clinic, Psychologist
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Distractibility, Disturbance in attention, Dysphonia, Electroencephalogram abnormal, Mental status changes
Clinical narrative: Fever 1 day, change in mental status, upper respiratory symptoms, paleness, x 1 week.  Followed by decreased attentiveness, distractability, staring off, staring at objects, side glancing, isolation, OCD behaviors, vocal sounds, posturing, seen on video tapes.  3/14/08 Reviewed PCP medical records. FINAL DX: autism Office records of 9/27/2006 reveal patient there for well child visit.  Able to ride tricycle, jump, speak 3 word sentences, tantrums, picky eater.  Next visit 1/19/2007 for URI.  Next visit 8/2007, parent concerned about possible PDD.  Poor eye contact, does not follow directions, tantrums & screaming, hyperactive, poor socialization in preschool.  Scheduled for neuropsychological & developmental pediatrician eval in 9/2007.  Referred for neuro consult 10/2007 after EEG revealed seizure disorder.  4/4/08 Reviewed neuropsychological evaluation of 10/4/07 provided by parent. FINAL DX: Autism & global developmental delay. Records reveal patient w/developmental delays, verbal & nonverbal communication disorder, social interaction disorder, repetitive activities, stereotypical movements, resistance to change, unusual responses to sensory experiences.    4/4/08 Reviewed neurology evaluation of 10/25/2007 provided by parent. FINAL DX: unable to determine Records reveal unable to adequately examine patient due to fear & screaming but neuro felt something was going on.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Obsessive-compulsive disorder, Pallor, Posturing, Pyrexia, Staring
Clinical narrative: Fever 1 day, change in mental status, upper respiratory symptoms, paleness, x 1 week.  Followed by decreased attentiveness, distractability, staring off, staring at objects, side glancing, isolation, OCD behaviors, vocal sounds, posturing, seen on video tapes.  3/14/08 Reviewed PCP medical records. FINAL DX: autism Office records of 9/27/2006 reveal patient there for well child visit.  Able to ride tricycle, jump, speak 3 word sentences, tantrums, picky eater.  Next visit 1/19/2007 for URI.  Next visit 8/2007, parent concerned about possible PDD.  Poor eye contact, does not follow directions, tantrums & screaming, hyperactive, poor socialization in preschool.  Scheduled for neuropsychological & developmental pediatrician eval in 9/2007.  Referred for neuro consult 10/2007 after EEG revealed seizure disorder.  4/4/08 Reviewed neuropsychological evaluation of 10/4/07 provided by parent. FINAL DX: Autism & global developmental delay. Records reveal patient w/developmental delays, verbal & nonverbal communication disorder, social interaction disorder, repetitive activities, stereotypical movements, resistance to change, unusual responses to sensory experiences.    4/4/08 Reviewed neurology evaluation of 10/25/2007 provided by parent. FINAL DX: unable to determine Records reveal unable to adequately examine patient due to fear & screaming but neuro felt something was going on.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Upper respiratory tract infection
Clinical narrative: Fever 1 day, change in mental status, upper respiratory symptoms, paleness, x 1 week.  Followed by decreased attentiveness, distractability, staring off, staring at objects, side glancing, isolation, OCD behaviors, vocal sounds, posturing, seen on video tapes.  3/14/08 Reviewed PCP medical records. FINAL DX: autism Office records of 9/27/2006 reveal patient there for well child visit.  Able to ride tricycle, jump, speak 3 word sentences, tantrums, picky eater.  Next visit 1/19/2007 for URI.  Next visit 8/2007, parent concerned about possible PDD.  Poor eye contact, does not follow directions, tantrums & screaming, hyperactive, poor socialization in preschool.  Scheduled for neuropsychological & developmental pediatrician eval in 9/2007.  Referred for neuro consult 10/2007 after EEG revealed seizure disorder.  4/4/08 Reviewed neuropsychological evaluation of 10/4/07 provided by parent. FINAL DX: Autism & global developmental delay. Records reveal patient w/developmental delays, verbal & nonverbal communication disorder, social interaction disorder, repetitive activities, stereotypical movements, resistance to change, unusual responses to sensory experiences.    4/4/08 Reviewed neurology evaluation of 10/25/2007 provided by parent. FINAL DX: unable to determine Records reveal unable to adequately examine patient due to fear & screaming but neuro felt something was going on.
Age: 0.17
Sex: M
Vaccine: DTAP
Symptoms: Coagulation test, Injection site erythema, Injection site induration
Clinical narrative: Indurated, erythematous area (possibly small hemorrhage) 1.5 cm in diameter noted on L thigh approx. 3 1/2 hours after DTaP administration.
Age: 19.0
Sex: F
Vaccine: HPVX
Symptoms: Culture, Fungal infection, Injection site pain, Laboratory test, Smear test
Clinical narrative: At the time of the injection (date is uncertain) and soon afterward only pain at site were a problem.  Within a week or so, a stubborn yeast infection started that is still recurring and never quite clears up even today, 4 months later, with agressive physician care and prolonged internal and external medical treatment.  As the HPV vaccine is yeast based, I believe there is a definite correlation.  There is no history previously of recurrent yeast infections in her.
Age: 1.51
Sex: F
Vaccine: MMR
Symptoms: Body temperature increased, Oedema peripheral, Purpura, Skin discolouration, Urticaria
Clinical narrative: Severe Hives occured within 24 hours of MMR vaccine administration.  Within 48 hours of MMR administration hands and feet were extremely swollen, temperature rose to 102.5 degrees and hives on thighs and feet turn purple.  Hives receded after 7 days, but reappeared on 8th day.  Mild hives continue to come and go for over 30 days.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Musculoskeletal pain, Neck pain, Pain in extremity, Tenderness
Clinical narrative: THREE DAYS AFTER THE VACCINE SHE DEVELOPED PAIN AND TENDERNESS FROM HER LEFT NECK AND SHOULDER DOWN THE ARM TO THE WRIST.  THE SYMPTOMS PEAKED IN THE FIRST 2-3 DAYS, THEN SUBSIDED SOMEWHAT BUT STILL PERSIST TO DATE.  WE'LL CONTINUE TO FOLLOW HER.
Age: 1.1
Sex: M
Vaccine: HEP, UNK
Symptoms: Incorrect dose administered
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of inappropriate dose of vaccine administered in a 2-month-old male subject who was vaccinated with Engerix B (GlaxoSmithKline) for prophylaxis.  Concurrent vaccinations included unspecified vaccine(s); given on 29 February 2008.  On 29 February 2008 at 13:00, the infant subject inadvertently received an adult dose of Engerix B (20 mcg, unknown) as his 2nd dose of the vaccine.  The reporting healthcare professional considered the event to be clinically significant (or requiring intervention).
Age: 74.0
Sex: F
Vaccine: PPV, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: -Pt got Pneumo shot in AM from 1st MD 3/03/08 in (L) arm. When told Zostavax shot may sting, asked if could get in (L) arm as well. I consented. Pt developed redness, pain, swelling in left arm. Pt believes use of concurrent shots in same arm causes the reactions.
Age: 52.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Headache, Pain, Pyrexia, Swelling
Clinical narrative: Reported pain, redness and swelling, feverish, body aches and headaches; Rx Alvelox; Administrator of vaccine notified of reaction on 3-6-08. Issue completely resolved at that time.
Age: 15.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Dizziness, Dysarthria, Feeling cold, Headache, Neurological examination
Clinical narrative: Gardasil (#1: 08/17/07) (#2 10-20-07) Dizziness (1) 09/17/07 Coldness (2) 01/17/08 Slurred speech with Headache.  04/07/2008 MR received from PCP beginning with WCC 5/2/2007 and including vax record and 2 ER records with DX: Vasovagal Syncope (9/19/2007) and Vasovagal episode, r/o seizure (1/16/2008). On 9//19/2007 pt presented to ER after near syncopal episode while running.  Pt felt dizzy and almost passed out.  Transported by EMS to ER.  PE WNL. Seen again 1/16/08 after a fall/shaking episode. Pt reported feeling cold and being unable to speak. Suttering upon arrival to ED.  PE WNL. D/C home to f/u as outpt. Seen by PCP 2/7/08 with c/o dizziness and pallor on 2/5/08. Under work-up
Age: 1.3
Sex: M
Vaccine: HEPA, MMR, PNC, VARCEL
Symptoms: Eyelid oedema, Pyrexia
Clinical narrative: Swollen eyelids and fever.
Age: 1.0
Sex: M
Vaccine: HEPA, HIBV, MMR
Symptoms: Measles, Rubella antibody positive, Vaccination failure
Clinical narrative: Broke out with measles 1 week after shot was confirmed with Rubella titers and a doctor from infection control
Age: 59.0
Sex: F
Vaccine: HEP, HEPA
Symptoms: Fatigue, Headache, Pain in extremity
Clinical narrative: Complained of sore arms, intermitted headache, fatigue 24 hours after vaccination.
Age: 18.0
Sex: M
Vaccine: HEPA, MNQ, HEPA, MNQ
Symptoms: Dizziness, Musculoskeletal stiffness, Pain
Clinical narrative: Initial report received on 22 February 2008 from a health care professional. A 17-year-old male patient, with no concurrent illnesses, or pre-existing medical history, had received a first, right deltoid dose of Menactra (lot number U2551AA); a second right forearm dose of Tubersol (lot number C2682AA); and a first, left deltoid dose of Hepatitis A (manufacturer Merck, lot number 0800U) on 21 February 2008 at 15:00 p.m. The route of administration was not reported for any of the vaccines, or the tuberculin test. Eighteen hours post-vaccination, and post tuberculin test, which was around 09:00 a.m. on 22 February 2008, the patient woke up with a stiff neck, generalized achiness, and dizziness. The patient was evaluated by his physician on the same day and was found to be afebrile. The patient was at the physician's office when this report was filed. Treatments received, and diagnostic tests performed were not provided. At the time of this report, the patient had not recovered.
Age: 18.0
Sex: M
Vaccine: HEPA, MNQ, HEPA, MNQ
Symptoms: Blood cholesterol normal, Culture throat positive, Dizziness, Full blood count normal, Headache
Clinical narrative: Initial report received on 22 February 2008 from a health care professional. A 17-year-old male patient, with no concurrent illnesses, or pre-existing medical history, had received a first, right deltoid dose of Menactra (lot number U2551AA); a second right forearm dose of Tubersol (lot number C2682AA); and a first, left deltoid dose of Hepatitis A (manufacturer Merck, lot number 0800U) on 21 February 2008 at 15:00 p.m. The route of administration was not reported for any of the vaccines, or the tuberculin test. Eighteen hours post-vaccination, and post tuberculin test, which was around 09:00 a.m. on 22 February 2008, the patient woke up with a stiff neck, generalized achiness, and dizziness. The patient was evaluated by his physician on the same day and was found to be afebrile. The patient was at the physician's office when this report was filed. Treatments received, and diagnostic tests performed were not provided. At the time of this report, the patient had not recovered.
Age: 18.0
Sex: M
Vaccine: HEPA, MNQ, HEPA, MNQ
Symptoms: Pain, Urine analysis normal
Clinical narrative: Initial report received on 22 February 2008 from a health care professional. A 17-year-old male patient, with no concurrent illnesses, or pre-existing medical history, had received a first, right deltoid dose of Menactra (lot number U2551AA); a second right forearm dose of Tubersol (lot number C2682AA); and a first, left deltoid dose of Hepatitis A (manufacturer Merck, lot number 0800U) on 21 February 2008 at 15:00 p.m. The route of administration was not reported for any of the vaccines, or the tuberculin test. Eighteen hours post-vaccination, and post tuberculin test, which was around 09:00 a.m. on 22 February 2008, the patient woke up with a stiff neck, generalized achiness, and dizziness. The patient was evaluated by his physician on the same day and was found to be afebrile. The patient was at the physician's office when this report was filed. Treatments received, and diagnostic tests performed were not provided. At the time of this report, the patient had not recovered.
Age: 65.0
Sex: U
Vaccine: VARZOS
Symptoms: Unevaluable event
Clinical narrative: No adverse events
Age: 18.0
Sex: M
Vaccine: RAB
Symptoms: Back pain, Pruritus, Rash
Clinical narrative: Donor c/o itching and had a rash the approximate size of a 50 cent piece on lt side of lower back also c/o lower back pain.
Age: 1.25
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Gait disturbance, X-ray normal
Clinical narrative: Child experienced knee joint pain in same leg where vaccine was administered.  Pain onset was 12 days post vaccination, and lasted for a week.  Child stopped walking for a week due to the joint pain.  No injury to affected joint was witnessed.
Age: 27.0
Sex: M
Vaccine: ANTH
Symptoms: Erythema, Injection site induration, Pain, Skin warm
Clinical narrative: Induration at injection site.  Erythema and warm to touch.  Painful, affecting RoM of left arm.  Pt marked to monitor growth, put quarters 24h.
Age: 1.26
Sex: M
Vaccine: DTAP, HIBV, MMR, PNC
Symptoms: Aphasia, Autism, Childhood disintegrative disorder, Cognitive disorder, Communication disorder
Clinical narrative: Pt ran a low grade fever for 24 hours after vaccinations, and over the next month he delined in regards to cognition.  He quit talking, lost eye contact, did not respond to his name, declined in his gross & fine motor abilities.  03/11/2008 MR received from PCP showing WCCs beginning 6/18/2004. Healthy with normal development noted at 9/9 and 12/9 2005 visits.  Speech regression noted at 6/7/06 visit and DX of Autism at 6/15/07 visit.  In therapy for speech delay. 3/31/08 MR received from ped dev specialist with dx c/w Autism. Pt had language regression and shows speech delays and poor communication skills, impaired social skills and repetitive/stereotyped behaviors which began at age 15-16 months. Follow-up: He is still primarily non-verbal. His language did not return. His academic level is still far below his age. He still has sensory issues. His eye contact has improved with hours and hours of ABA-type therapy, speech therapy, social therapy, and occupational therapy, but he still holds on obvious Autism diagnosis that was not evident until the vaccinations listed above were given to him. My daughter did not receive these vaccines and she is neurotypical. We have him in speech therapy, occupational therapy & developmental therapy, but he has speech & language and is learning to talk again. Since the vaccination he has not progressed developmentally. He seems to function at about a 16-18 month-old and will be 4 y.o. on mon.
Age: 1.26
Sex: M
Vaccine: DTAP, HIBV, MMR, PNC
Symptoms: Decreased eye contact, Disturbance in social behaviour, Laboratory test, Pyrexia, Staring
Clinical narrative: Pt ran a low grade fever for 24 hours after vaccinations, and over the next month he delined in regards to cognition.  He quit talking, lost eye contact, did not respond to his name, declined in his gross & fine motor abilities.  03/11/2008 MR received from PCP showing WCCs beginning 6/18/2004. Healthy with normal development noted at 9/9 and 12/9 2005 visits.  Speech regression noted at 6/7/06 visit and DX of Autism at 6/15/07 visit.  In therapy for speech delay. 3/31/08 MR received from ped dev specialist with dx c/w Autism. Pt had language regression and shows speech delays and poor communication skills, impaired social skills and repetitive/stereotyped behaviors which began at age 15-16 months. Follow-up: He is still primarily non-verbal. His language did not return. His academic level is still far below his age. He still has sensory issues. His eye contact has improved with hours and hours of ABA-type therapy, speech therapy, social therapy, and occupational therapy, but he still holds on obvious Autism diagnosis that was not evident until the vaccinations listed above were given to him. My daughter did not receive these vaccines and she is neurotypical. We have him in speech therapy, occupational therapy & developmental therapy, but he has speech & language and is learning to talk again. Since the vaccination he has not progressed developmentally. He seems to function at about a 16-18 month-old and will be 4 y.o. on mon.
Age: 0.68
Sex: F
Vaccine: DTAP, FLUX, HIBV, PNC
Symptoms: Breath holding, Inappropriate schedule of drug administration, Personality change, Pyrexia, Respiratory arrest
Clinical narrative: Fever of 102 that night, high pitched scream, stopped breathing for a minute.  Doctor was very nonchalant.  Told me to give her Motrin to bring down her fever. Never shared with us that she had an adverse reaction.  2 weeks later, she stopped breathing in my arms again when I asked the doctor about this; she said she was holding her breath on purpose.  Any time patient has ever had shots, her personality would change for about a week.  Usually a very docile and delightful baby, she would actually glare at people, bite and slap when she wasn't getting her way.  A week would pass and she'd go back to being herself.
Age: 0.68
Sex: F
Vaccine: DTAP, FLUX, HIBV, PNC
Symptoms: Screaming
Clinical narrative: Fever of 102 that night, high pitched scream, stopped breathing for a minute.  Doctor was very nonchalant.  Told me to give her Motrin to bring down her fever. Never shared with us that she had an adverse reaction.  2 weeks later, she stopped breathing in my arms again when I asked the doctor about this; she said she was holding her breath on purpose.  Any time patient has ever had shots, her personality would change for about a week.  Usually a very docile and delightful baby, she would actually glare at people, bite and slap when she wasn't getting her way.  A week would pass and she'd go back to being herself.
Age: 1.3
Sex: F
Vaccine: MMRV, PPV
Symptoms: Convulsion, Electroencephalogram, Febrile convulsion, Metabolic function test, Nuclear magnetic resonance imaging brain abnormal
Clinical narrative: Information has been received from the FDA (VAERS # 255019) concerning a 15 month old female with metabolic disorder who on 27-APR-2006 was vaccinated with measles virus vaccine (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process  {Lot # 652234/0951R0) subcutaneously in the right leg. Concomitant therapy included PNEUMOVAX (pneumococcal 14v polysaccharide vaccine). On 02-MAY-2006, 5 days post vaccination the patient started vomiting followed by recurrent afebrile seizures, some with localizing signs. The patient was hospitalized for three days. The patient had a metabolic work up, EEG, CT and MRI of the brain which was abnormal, done. It was also noted that the patient had an unknown metabolic defect suspected short chain acl  co a dehydrogenase deficiency (work-up in progress diagnosis not confirmed). It was reported the events were life threatening. Subsequently, the patient recovered from vomiting, convulsion and febrile convulsion after five days. A lot check has been requested. A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional informtion has been requested.
Age: 1.3
Sex: F
Vaccine: MMRV, PPV
Symptoms: Scan brain, Vomiting
Clinical narrative: Information has been received from the FDA (VAERS # 255019) concerning a 15 month old female with metabolic disorder who on 27-APR-2006 was vaccinated with measles virus vaccine (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process  {Lot # 652234/0951R0) subcutaneously in the right leg. Concomitant therapy included PNEUMOVAX (pneumococcal 14v polysaccharide vaccine). On 02-MAY-2006, 5 days post vaccination the patient started vomiting followed by recurrent afebrile seizures, some with localizing signs. The patient was hospitalized for three days. The patient had a metabolic work up, EEG, CT and MRI of the brain which was abnormal, done. It was also noted that the patient had an unknown metabolic defect suspected short chain acl  co a dehydrogenase deficiency (work-up in progress diagnosis not confirmed). It was reported the events were life threatening. Subsequently, the patient recovered from vomiting, convulsion and febrile convulsion after five days. A lot check has been requested. A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional informtion has been requested.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Albumin CSF increased, Blood product transfusion, Borrelia burgdorferi serology negative, CSF immunoglobulin increased, CSF myelin basic protein
Clinical narrative: This case was received from the Centers for Disease Control and Prevention (CDC) on 11 December 2007 under VAERS reference number 297573. An 18-year-old male patient, with no known medical history, received an intramuscular left arm injection of Menactra (lot number U2278AA) on 22 August 2007. On 18 September 2007, he presented to the student health center with complaints of muscle pain and intermittent tingling in the extremities. He was seen in the health center on 19 September 2007, 20 September 2007, and 21 September 2007, at which time his symptoms were noted to be persistent but unchanged. On 24 September 2007 he complained of weakness in the legs and difficulty swallowing. He was seen in the emergency room, and a CT of the head and x-ray of the cervical spine were normal. He was diagnosed with a neck sprain and discharged the same day. On 25 September 2007 he presented to the health center with increased weakness and neurological changes. He was admitted to the hospital and diagnosed with Guillain-Barre Syndrome (GBS). CSF laboratory findings were as follows: Albumin 103, IgG 19.1, protein 143, WBC's 5-10, RBC (+); cryptococcus antigen negative, culture negative, Lyme negative, HSV (herpes simplex virus) negative, drug screen negative. No virus was isolated. Myelin base protein was 1.5 (reference ranges and units were not provided). Per the treating physician, EMG (electromyogram) and NCS (nerve conduction studies) were positive for GBS. Neurological and infectious disease consults were obtained, and the patient was treated with five doses of intravenous immunoglobulin G. A gradual improvement was noted and the patient was discharged on 01 October 2007. He received occupational and physical therapy at home, and the event resolved. At the time of the report, the event was being evaluated by CISA using the Brighton Collaboration's most recent case definition for Guillain Barre Syndrome.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: CSF protein increased, CSF white blood cell count, Computerised tomogram normal, Culture negative, Drug screen negative
Clinical narrative: This case was received from the Centers for Disease Control and Prevention (CDC) on 11 December 2007 under VAERS reference number 297573. An 18-year-old male patient, with no known medical history, received an intramuscular left arm injection of Menactra (lot number U2278AA) on 22 August 2007. On 18 September 2007, he presented to the student health center with complaints of muscle pain and intermittent tingling in the extremities. He was seen in the health center on 19 September 2007, 20 September 2007, and 21 September 2007, at which time his symptoms were noted to be persistent but unchanged. On 24 September 2007 he complained of weakness in the legs and difficulty swallowing. He was seen in the emergency room, and a CT of the head and x-ray of the cervical spine were normal. He was diagnosed with a neck sprain and discharged the same day. On 25 September 2007 he presented to the health center with increased weakness and neurological changes. He was admitted to the hospital and diagnosed with Guillain-Barre Syndrome (GBS). CSF laboratory findings were as follows: Albumin 103, IgG 19.1, protein 143, WBC's 5-10, RBC (+); cryptococcus antigen negative, culture negative, Lyme negative, HSV (herpes simplex virus) negative, drug screen negative. No virus was isolated. Myelin base protein was 1.5 (reference ranges and units were not provided). Per the treating physician, EMG (electromyogram) and NCS (nerve conduction studies) were positive for GBS. Neurological and infectious disease consults were obtained, and the patient was treated with five doses of intravenous immunoglobulin G. A gradual improvement was noted and the patient was discharged on 01 October 2007. He received occupational and physical therapy at home, and the event resolved. At the time of the report, the event was being evaluated by CISA using the Brighton Collaboration's most recent case definition for Guillain Barre Syndrome.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Dysphagia, Electromyogram abnormal, Guillain-Barre syndrome, Herpes simplex serology negative, Muscular weakness
Clinical narrative: This case was received from the Centers for Disease Control and Prevention (CDC) on 11 December 2007 under VAERS reference number 297573. An 18-year-old male patient, with no known medical history, received an intramuscular left arm injection of Menactra (lot number U2278AA) on 22 August 2007. On 18 September 2007, he presented to the student health center with complaints of muscle pain and intermittent tingling in the extremities. He was seen in the health center on 19 September 2007, 20 September 2007, and 21 September 2007, at which time his symptoms were noted to be persistent but unchanged. On 24 September 2007 he complained of weakness in the legs and difficulty swallowing. He was seen in the emergency room, and a CT of the head and x-ray of the cervical spine were normal. He was diagnosed with a neck sprain and discharged the same day. On 25 September 2007 he presented to the health center with increased weakness and neurological changes. He was admitted to the hospital and diagnosed with Guillain-Barre Syndrome (GBS). CSF laboratory findings were as follows: Albumin 103, IgG 19.1, protein 143, WBC's 5-10, RBC (+); cryptococcus antigen negative, culture negative, Lyme negative, HSV (herpes simplex virus) negative, drug screen negative. No virus was isolated. Myelin base protein was 1.5 (reference ranges and units were not provided). Per the treating physician, EMG (electromyogram) and NCS (nerve conduction studies) were positive for GBS. Neurological and infectious disease consults were obtained, and the patient was treated with five doses of intravenous immunoglobulin G. A gradual improvement was noted and the patient was discharged on 01 October 2007. He received occupational and physical therapy at home, and the event resolved. At the time of the report, the event was being evaluated by CISA using the Brighton Collaboration's most recent case definition for Guillain Barre Syndrome.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Myalgia, Neck injury, Nerve conduction studies abnormal, Paraesthesia, Red blood cells CSF positive
Clinical narrative: This case was received from the Centers for Disease Control and Prevention (CDC) on 11 December 2007 under VAERS reference number 297573. An 18-year-old male patient, with no known medical history, received an intramuscular left arm injection of Menactra (lot number U2278AA) on 22 August 2007. On 18 September 2007, he presented to the student health center with complaints of muscle pain and intermittent tingling in the extremities. He was seen in the health center on 19 September 2007, 20 September 2007, and 21 September 2007, at which time his symptoms were noted to be persistent but unchanged. On 24 September 2007 he complained of weakness in the legs and difficulty swallowing. He was seen in the emergency room, and a CT of the head and x-ray of the cervical spine were normal. He was diagnosed with a neck sprain and discharged the same day. On 25 September 2007 he presented to the health center with increased weakness and neurological changes. He was admitted to the hospital and diagnosed with Guillain-Barre Syndrome (GBS). CSF laboratory findings were as follows: Albumin 103, IgG 19.1, protein 143, WBC's 5-10, RBC (+); cryptococcus antigen negative, culture negative, Lyme negative, HSV (herpes simplex virus) negative, drug screen negative. No virus was isolated. Myelin base protein was 1.5 (reference ranges and units were not provided). Per the treating physician, EMG (electromyogram) and NCS (nerve conduction studies) were positive for GBS. Neurological and infectious disease consults were obtained, and the patient was treated with five doses of intravenous immunoglobulin G. A gradual improvement was noted and the patient was discharged on 01 October 2007. He received occupational and physical therapy at home, and the event resolved. At the time of the report, the event was being evaluated by CISA using the Brighton Collaboration's most recent case definition for Guillain Barre Syndrome.